1. Introduction {#sec1-molecules-25-02525}
===============

*Gymnema sylvestre* (Retz.) R.Br. ex Sm. (Apocynaceae) is a perennial woody climber native to tropical and subtropical regions, such as India, Africa, and southeast Asia. In folk medicine, *G. sylvestre* have been used to treat snake bites, arthritis, digestive, and enhancing laxative \[[@B1-molecules-25-02525],[@B2-molecules-25-02525]\]. Moreover, the plant has been explored for its benefits in blocking sugar craving and reducing sugar consumption. The recent studies have indicated that *G. sylvestre* are potential anti-diabetic plants \[[@B3-molecules-25-02525],[@B4-molecules-25-02525]\]. The bioactive components from this plant include pregnane glycosides \[[@B5-molecules-25-02525]\], triterpene saponins \[[@B6-molecules-25-02525],[@B7-molecules-25-02525]\], and flavonoids \[[@B8-molecules-25-02525]\]. Our previous study reported pregnane glycosides from *Gymnema inodorum* and their α-glucosidase inhibitory activity \[[@B9-molecules-25-02525]\]. As a part of our ongoing investigation on anti-diabetic compounds from Vietnamese plants \[[@B10-molecules-25-02525]\], a methanol extract of the leaves of *G. sylvestre* was found to inhibit α-glucosidase and α-amylase activities. Herein, we report the isolation, structural elucidation of pregnane-type saponins and oleanane saponins and the evaluation of α-glucosidase and α-amylase inhibitory activities of these compounds.

2. Results and Discussion {#sec2-molecules-25-02525}
=========================

2.1. Isolation of Compounds {#sec2dot1-molecules-25-02525}
---------------------------

The methanol extract of the *G. sylvestre* leaves was suspended in water and then partitioned with *n*-hexane, CH~2~Cl~2~ and EtOAc to obtain four layers. The CH~2~Cl~2~ and water extracts were chromatographed using combined silica gel and RP-18 columns. The fractions were further purified by HPLC to give five new pregnane glycosides and four known compounds ([Figure 1](#molecules-25-02525-f001){ref-type="fig"} and [Supplementary Materials](#app1-molecules-25-02525){ref-type="app"}).

2.2. Compound Identification {#sec2dot2-molecules-25-02525}
----------------------------

Compound **1** was obtained as a white amorphous powder. Its molecular formula was determined as C~47~H~76~O~17~ by HRESIMS ion at *m*/*z* 935.4986 \[M + Na\]^+^ (calcd for \[C~47~H~76~O~17~Na\]^+^, 935.4975). The ^1^H-NMR spectrum showed proton signals of three methyl groups at *δ*~H~ 1.13 (3H, s), 1.53 (3H, s), and 1.05 (3H, d, *J* = 6.4 Hz), one olefinic proton at *δ*~H~ 5.32 (1H, br s), which represented a pregnane aglycone. Two methyl groups at *δ*~H~ 1.80 (3H, d, *J* = 7.2 Hz) and 1.85 (3H, s) and one olefinic proton at *δ*~H~ 6.98 (1H, q, *J* = 7.2 Hz), suggested the presence of a tigloyl moiety. Three anomeric protons \[*δ*~H~ 4.84 (br d, *J* = 9.6 Hz), 4.57 (br d, *J* = 9.2 Hz), and 4.41 (br d, *J* = 8.0 Hz), three methoxy groups \[*δ*~H~ 3.39, 3.42, and 3.60 (each 3H, s)\], together with three secondary methyl groups \[*δ*~H~ 1.19 (3H, d, *J* = 6.0 Hz), 1.25 (d, *J* = 6.0 Hz), and 1.35 (d, *J* = 6.0 Hz)\], confirmed the presence of three sugar units. The ^13^C NMR and DEPT spectra indicated that **1** contained one carbonyl, seven non-protonated carbons (three oxygenated), nineteen methines (sixteen oxygenateds), nine methylenes, and eleven methyl carbons (three methoxys). The ^1^H and ^13^C-NMR spectroscopic data suggested that **1** was a pregnane glycoside \[[@B11-molecules-25-02525]\]. Of these, 21 carbons were assigned to the pregnane skeleton, 5 to one tigloyl moiety, and 21 to a trisaccharide moiety. The HMBC correlations between H-19 (*δ*~H~ 1.13) and C-1 (*δ*~C~ 39.8)/C-5 (*δ*~C~ 140.0)/C-9 (*δ*~C~ 44.7)/C-10 (*δ*~C~ 38.0) suggested the position of a double bond at C-5/C-6. The HMBC correlations between H-18 (*δ*~H~ 1.53) and C-13 (*δ*~C~ 57.6)/C-14 (*δ*~C~ 89.3)/C-17 (*δ*~C~ 89.1); between H-21 (*δ*~H~ 1.05) and C-17 (*δ*~C~ 89.1)/C-20 (*δ*~C~ 71.5); and between H-6 (*δ*~H~ 5.32)/H-7 (*δ*~H~ 2.11)/H-9 (*δ*~H~ 1.49) and C-8 (*δ*~C~ 74.9) demonstrated the positions of hydroxyl groups at C-8, C-14, C-17, and C-20 ([Figure 2](#molecules-25-02525-f002){ref-type="fig"}). The constitution of the aglycone of **1** was demonstrated by the analysis of NOESY observations and similar reported-structures \[[@B11-molecules-25-02525]\].

The aglycone of **1** was supposed to have the same configurations as those of gymnepregoside F and 12-*O*-(*E*)-cinnamoylgymnepregoside F from *G. sylvestre* \[[@B12-molecules-25-02525]\], biogenetic derivatives of **1** at C-3, C-8, C-12, C-14, C-17, and C-20. In addition, the alkaline hydrolysis of **1** gave sarcostin, ((20*S*)-3β,8β,12β,14β,17β,20-hexahydroxypregn-5-ene) \[[@B13-molecules-25-02525]\]. The multiplicity of H-12 \[*δ*~H~ 4.68 (dd, *J* = 4.0, 11.6 Hz)\] suggested that the configuration of H-12 was *axial* (α-configuration, [Figure 2](#molecules-25-02525-f002){ref-type="fig"}). The NOESY correlations between H-3 (*δ*~H~ 3.50) and H~α~-1 (*δ*~H~ 1.09)/ H~α~-4 (*δ*~H~ 2.33), and between H-12 (*δ*~H~ 4.68) and H-9 (*δ*~H~ 1.49)/H~α~-15 (*δ*~H~ 1.88) suggested the configurations of the oxygenated groups at C-3 and C-12, the hydroxy groups at C-8 and C-14 to be β. The HMBC correlations between Tig H-5 (*δ*~H~ 1.85) and Tig C-1 (*δ*~C~ 169.1)/Tig C-2 (*δ*~C~ 130.0)/Tig C-3 (*δ*~C~ 139.5) and between Tig H-4 (*δ*~H~ 1.80) and Tig C-2/ Tig C-3 and NOESY correlations between Tig H-4 (*δ*~H~ 1.80) and Tig H-5 (*δ*~H~ 1.85) suggested the presence of (*E*)-tigloyl moiety. In addition, the position of this moiety at C-12 was confirmed by HMBC correlation from H-12 (*δ*~H~ 4.68) to Tig C-1 (*δ*~C~ 169.1). Acid hydrolysis of **1** gave three monosaccharides, which were identified as D-cymarose \[[@B14-molecules-25-02525]\], D-oleandrose \[[@B14-molecules-25-02525]\], and D-thevetose \[[@B15-molecules-25-02525]\], by comparing their specific rotation with those reported \[[@B16-molecules-25-02525]\]. The large coupling constants between H-1 and H-2 of monosaccharide moieties and also HMBC correlations between Thv H-1 (*δ*~H~ 4.41) and Ole C-4 (*δ*~C~ 84.1), Ole H-1 (*δ*~H~ 4.57) and Cym C-4 (*δ*~C~ 83.8), and between Cym H-1 (*δ*~H~ 4.84) and aglycone C-3 (*δ*~H~ 79.2) indicated the sugar linkages as β-D-thevetopyranosyl-(1→4)-β-D-oleandropyranosyl- (1→4)-β-D-cymaropyranoside and at C-3 of aglycone. Based on the above evidence, the structure of **1** was elucidated as (20*S*)-12β-tigloyloxy-3β,8β,14β,17β,20-pentahydroxypregn-5-ene 3-*O*-β-D-thevetopyranosyl- (1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranoside, a new compound named gymsyloside A.

The ^1^H and ^13^C-NMR spectra of **2** exhibited a pregnane aglycone, one tigloyl unit, and three sugar units ([Table 1](#molecules-25-02525-t001){ref-type="table"}). In addition, the NMR data of **2** were similar to those of gymsyloside A (**1**), except for the difference of sugar unit at Ole C-4: D-thevetose replaced by 6-deoxy-3-*O*-methyl-D-allose. Acid hydrolysis of **2** confirmed the presence of D-cymarose, D-oleandrose, and 6-deoxy-3-*O*-methyl-D-allose as sugar components. Furthermore, the ^1^H and ^13^C-NMR data of **2** showed the sugar units as β-D-cymaropyranosyl, β-D-oleandropyranosyl, and 6-deoxy-3-*O*-methyl-β-D-allopyranose. The HMBC correlations between All H-1 (*δ*~H~ 4.70) and Ole C-4 (*δ*~C~ 84.0), Ole H-1 (*δ*~H~ 4.56) and Cym C-4 (*δ*~C~ 83.8), and between Cym H-1 (*δ*~H~ 4.85) and aglycone C-3 (*δ*~C~ 79.3) confirmed the sugar linkages to be 3-*O*-6-deoxy-3-*O*-methyl-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranoside. Consequently, compound **2** was elucidated to be (20*S)*-12β-tigloyloxy-3β,8β,14β,17β,20-pentahydroxypregn-5-ene 3-*O*-6-deoxy-3-*O*-methyl-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranoside, a new compound named gymsyloside B.

The HRESIMS of **3** gave a pseudo-molecular ion peak at *m*/*z* 1079.5769 \[M + Na\]^+^, corresponding to the molecular formula of C~54~H~88~O~20~. The ^1^H and ^13^C-NMR spectra of **3** showed the presence of one pregnane aglycone, four sugar units, and one tigloyl unit ([Table 1](#molecules-25-02525-t001){ref-type="table"}). The NMR data of **3** were compared to gymsyloside A (**1**) and found the addition of one sugar unit in the sugar linkages. Acid hydrolysis of **3** gave three monosaccharides, which were identified as D-cymarose, D-oleandrose, and D-thevetose. The tetrasaccharide was determined to be β-D-thevetopyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, by the analysis of HMBC and COSY correlations. The location of sugar linkages at C-3 was confirmed by the HMBC correlation between Cym I H-1 (*δ*~H~ 4.84) and C-3 (*δ*~C~ 79.3). Consequently, the structure of **3** was determined to be (20*S*)-12β-tigloyloxy-3β,8β,14β,17β, 20-pentahydroxypregn-5-ene 3-*O*-β-D-thevetopyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, a new compound named gymsyloside C.

The molecular formula of **4** was determined as C~54~H~88~O~20~ by the HRESIMS. The ^1^H and ^13^C-NMR data ([Table 2](#molecules-25-02525-t002){ref-type="table"}) indicated that the structure of **4** was similar to those of **3**, except for the difference of monosaccharide at Ole C-4. The sugar components were found to be similar to those of **2** (D-cymarose, D-oleandrose, and 6-deoxy-3-*O*-methyl-D-allose) \[[@B17-molecules-25-02525]\]. Moreover, the sugar linkages, 3-*O*-6-deoxy-3-*O*-methyl-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside was confirmed by the HMBC correlations from All H-1 (*δ*~H~ 4.70) to Ole C-4 (*δ*~C~ 83.7), Ole H-1 (*δ*~H~ 4.56) to Cym II C-4 (*δ*~C~ 83.8), and from Cym II H-1 (*δ*~H~ 4.77) to Cym I C-4 (*δ*~C~ 83.8). Similar to those of **1**--**3**, the aglycone was found as (20*S)*-12β-tigloyloxy-3β,8β,14β,17β, 20-pentahydroxypregn-5-ene. Consequently, the structure of **4** was determined as (20*S)*- 12β-tigloyloxy-3β,8β,14β,17β,20-pentahydroxypregn-5-ene 3-*O*-6-deoxy-3-*O*-methyl-β-D- allopyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside and named gymsyloside D.

The molecular formula of **5,** C~53~H~86~O~22~ was determined by the HRESIMS pseudo-ion at *m*/*z* 1097.5530 \[M + Na\]^+^. The ^1^H and ^13^C NMR data of **5** were similar to **2**, except for an additional sugar unit at Thv C-4 ([Table 2](#molecules-25-02525-t002){ref-type="table"}). The sugar moieties were determined as D-cymarose \[[@B14-molecules-25-02525]\], D-oleandrose \[[@B14-molecules-25-02525]\], D-thevetose \[[@B15-molecules-25-02525]\], and D-glucose \[[@B17-molecules-25-02525]\] by acid hydrolysis. The HMBC correlations between Glc H-1 (*δ*~H~ 4.41) and Thv C-4 (*δ*~C~ 82.9), Thv H-1 (*δ*~H~ 4.43) and Ole C-4 (*δ*~C~ 84.1), Ole H-1 (*δ*~H~ 4.57) and Cym C-4 (*δ*~C~ 83.8), and between Cym H-1 (*δ*~H~ 4.84) and aglycone C-3 (*δ*~C~ 79.3) confirmed the sequence of sugar linkages, previously reproted from *G. sylvestre* \[[@B5-molecules-25-02525]\]. Thus, compound **5** was characterized as (20*S)*-12β-tigloyloxy-3β,8β,14β,17β,20-pentahydroxypregn-5-ene 3-*O*-β-D-glucopyranosyl-(1→4)-β-D-thevetopyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranoside and named gymsyloside E.

The known compounds were identified as 3β-*O-*β-D-glucopyranosyl (1→6)-β-D-glucopyranosyl oleanolic acid 28-*O-*β-D-glucopyranosyl ester (**6**) \[[@B7-molecules-25-02525]\], gymnemoside-W1 (**7**) \[[@B18-molecules-25-02525]\], 3β-*O-*β-D-xylopyranosyl-(1→6)-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl oleanolic acid 28-*O-*β-D-glucopyranosyl ester (**8**) \[[@B7-molecules-25-02525]\], and alternoside XIX (**9**) \[[@B18-molecules-25-02525]\]. These compounds were already reported from *G. sylvestre*. Thus, for oleanane saponins, the main components could be hightly species-specific of *G. sylvestre* \[[@B7-molecules-25-02525],[@B18-molecules-25-02525]\]. In addition, new pregnane glycosides were also found in *G. alternifolium* \[[@B19-molecules-25-02525]\], *G. sylvestre* \[[@B5-molecules-25-02525]\], and *G. griffithii* \[[@B15-molecules-25-02525]\]. Five new pregnane glycosides in this report will contribute specific compounds in *Gymnema* genus.

2.3. α-Glucosidase and α-Amylase Inhibitory Activities {#sec2dot3-molecules-25-02525}
------------------------------------------------------

All compounds were evaluated for the α-glucosidase and α-amylase inhibitory assays. Compound **4** showed the weak α-glucosidase inhibitory activity (16.4 ± 2.3%) at the concentration of 200 µM, compared tos the positive control, acarbose (inhibition percentage of 57.8 ± 3.2% at the concentration of 155 µM) ([Figure 3](#molecules-25-02525-f003){ref-type="fig"}). Compounds **2**--**4** showed α-amylase inhibitory activity with inhibition percent ranging from 57.9% to 66.8% at the concentration of 200 µM ([Figure 4](#molecules-25-02525-f004){ref-type="fig"}). In the subsequent concentration-dependent assay, compounds **2**, **3**, and **4** showed significant α-amylase inhibitory activity, with IC~50~ values of 175.8 ± 2.3, 162.2 ± 2.7, and 113.0 ± 0.7 µM, respectively, compared to positive control, acarbose (IC~50~ value of 72.4 ±0.8 µM). This is the first report of α-glucosidase and α-amylase inhibitory activities of compounds from *G. sylvestre.* Recent reports have shown insulin secretion stimulation of *G. sylvestre* extract \[[@B4-molecules-25-02525]\], antihyperglycemic effects of gmynemic acids \[[@B20-molecules-25-02525]\], α-glucosidase and α-amylase inhibitory activities of pregnane glycosides from *G. latifolium* \[[@B11-molecules-25-02525]\]. Previous studies have indicated that pregnane glycosides from *G. griffithii* showed moderate α-glucosidase inhibitory activity \[[@B15-molecules-25-02525]\]. Russelioside B, a pregnane glycoside, possessed antidiabetic and antihyperlipidemic effect in streptozotocin induced diabetic rats \[[@B21-molecules-25-02525]\]. Therefore, the results suggest that the discovery of pregane glycosides may increase the possibility of finding antidiabetic agents.

3. Materials and Methods {#sec3-molecules-25-02525}
========================

3.1. General {#sec3dot1-molecules-25-02525}
------------

All NMR spectra were recorded on an Agilent 400-MR-NMR (Agilent technologies, Santa Clara, CA, USA) spectrometer operated at 400 and 100 MHz for hydrogen and carbon, respectively. Data processing was carried out with the MestReNova ver.6.0.2 program. HRESIMS spectra were obtained using an AGILENT 6550 iFunnel Q-TOF LC/MS system (Agilent technologies, Santa Clara, CA, USA). Optical rotations were determined on a Jasco DIP-370 automatic polarimeter. Preparative HPLC was carried out using an AGILENT 1200 HPLC system. Column chromatography was performed on silica-gel (Kieselgel 60, 70--230 mesh and 230--400 mesh, Merck) or YMC RP-18 resins (30--50 µm, Fuji Silysia Chemical Ltd., Aichi, Japan). For thin layer chromatography (TLC), a pre-coated silica-gel 60 F254 (0.25 mm, Merck, Darmstadt, Germany) and RP-18 F254S plates (0.25 mm, Merck, Darmstadt, Germany) were used.

3.2. Plant Material {#sec3dot2-molecules-25-02525}
-------------------

The leaves of *Gymnema sylvestre* (Retz.) R.Br. ex Sm. were collected in Hai Loc, Hai Hau, Nam Dinh in November, 2015, and identified by Dr. Nguyen The Cuong, Institute of Ecology and Biological Resources. A voucher specimen (NCCT-P20) was deposited at the Herbarium Institute of Marine Biochemistry, VAST.

3.3. Extraction and Isolation {#sec3dot3-molecules-25-02525}
-----------------------------

The dried powders of *G. sylvestre* leaves (4.0 kg) were sonicated with hot methanol (3 times × 10 L, each 3 h) to give MeOH extract (450 g), after evaporation of the solvent. The MeOH extract was suspended in water and successively partitioned with *n*-hexane, CH~2~Cl~2~ and EtOAc to obtain the *n*-hexane (GS1, 47.0 g), CH~2~Cl~2~ (GS2, 60.0 g), EtOAc extracts (GS3, 27.0 g) and H~2~O layer (GS4). GS2 was chromatographed on a silica gel column (180.0 g, silica gel) eluting with gradient solvent of *n*-hexane:acetone (40:1, 20:1, 10:1, 5:1, 1:1, and 0:1, *v*/*v*, each 2 L), to give seven fractions, GS2A-GS2G. The GS2F fraction was chromatographed on a silica gel column eluting with CHCl~3~:MeOH (11:1, *v*/*v*) to give four fractions, GS2F1-GS2F4. GS2F1 was chromatographed on a RP-18 column using MeOH:H~2~O (4:1, *v*/*v*) as a solvent, to give five fractions, GS2F1A-GS2F1E. Compounds **1** (17.0 mg, t~R~ 38.5 min) and **2** (9.0 mg, t~R~ 42.1 min) were yielded from GS2F1B fraction using HPLC system: J'sphere H-80 column (150 × 20 mm), flow rate of 3 mL/min, and solvent condition of 40% acetonitrile in water. Compounds **3** (5.0 mg, t~R~ 44.7 min) and **4** (5.0 mg, t~R~ 49.4 min) were yielded from GS2F1D fraction on J'sphere H-80 column (150 × 20 mm), flow rate of 3 mL/min, and solvent condition of 40% acetonitrile in water. GS2G was chromatographed on RP-18 column eluting with MeOH:H~2~O (4:1, *v*/*v*) to give four smaller fractions, GS2G1-GS2G4. Finally, GS2G3 was chromatographed on J'sphere H-80 column (150 × 20 mm), flow rate of 3 mL/min, and solvent condition of 35% acetonitrile in water to yield compound **5** (14.0 mg, t~R~ 39.7 min). GS4 was chromatographed on a Diaion column and eluted with H~2~O then increased concentrations of MeOH in H~2~O, to obtain sub-fractions, GS4A-GS4C. GS4C was chromatographed on a silica gel column eluting with a gradient of CHCl~3~:MeOH (20:1, 10:1, 5:1, 1:1, *v*/*v*) to give smaller fractions, GS4C1-GS4C4. GS4C4 was chromatographed on an RP-18 CC eluting with MeOH:water (2:1, *v*/*v*) to give smaller fractions, GS4C4A-GS4C4E. GS4C4B was chromatographed on an RP-18 column eluting with acetone:H~2~O (0.8:1, *v*/*v*) to yield **7** (5.0 g) and **9** (40.0 mg). GS4C4E was chromatographed on an RP-18 column eluting with acetone:H~2~O (1:1, *v*/*v*), to yield **6** (100.0 mg) and **8** (5.0 mg).

### 3.3.1. Gymsyloside A (**1**) {#sec3dot3dot1-molecules-25-02525}

White amorphous powder; $\left\lbrack \alpha \right\rbrack_{D}^{25}$ −20.0 (*c* 0.1, MeOH); C~47~H~76~O~17~, HRESIMS *m*/*z*: 935.4986 \[M + Na\]^+^ (calcd for \[C~47~H~76~O~17~Na\]^+^, 935.4975); ^1^H (CD~3~OD, 400 MHz) and ^13^C-NMR (CD~3~OD, 100 MHz) data, see [Table 1](#molecules-25-02525-t001){ref-type="table"}.

### 3.3.2. Gymsyloside B (**2**) {#sec3dot3dot2-molecules-25-02525}

White amorphous powder; $\left\lbrack \alpha \right\rbrack_{D}^{25}$ + 35.0 (*c* 0.1, MeOH); C~47~H~76~O~17~, HRESIMS *m*/*z*: 935.4996 \[M + Na\]^+^ (calcd for \[C~47~H~76~O~17~Na\]^+^, 935.4975); ^1^H (CD~3~OD, 400 MHz) and ^13^C-NMR (CD~3~OD, 100 MHz) data, see [Table 1](#molecules-25-02525-t001){ref-type="table"}.

### 3.3.3. Gymsyloside C (**3**) {#sec3dot3dot3-molecules-25-02525}

White amorphous powder; $\left\lbrack \alpha \right\rbrack_{D}^{25}$ + 80.0 (*c* 0.1, MeOH); C~54~H~88~O~20~, HRESIMS *m*/*z*: 1079.5769 \[M + Na\]^+^ (calcd for \[C~54~H~88~O~20~Na\]^+^, 1079.5769); ^1^H (CD~3~OD, 400 MHz) and ^13^C-NMR (CD~3~OD, 100 MHz) data, see [Table 1](#molecules-25-02525-t001){ref-type="table"}.

### 3.3.4. Gymsyloside D (**4**) {#sec3dot3dot4-molecules-25-02525}

White amorphous powder; $\left\lbrack \alpha \right\rbrack_{D}^{25}$+ 58.7 (*c* 0.1, MeOH); C~54~H~88~O~20~, HRESIMS *m*/*z*: 1079.5778 \[M + Na\]^+^ (calcd for \[C~54~H~88~O~20~Na\]^+^, 1079.5769); ^1^H (CD~3~OD, 400 MHz) and ^13^C-NMR (CD~3~OD, 100 MHz) data, see [Table 2](#molecules-25-02525-t002){ref-type="table"}.

### 3.3.5. Gymsyloside E (**5**) {#sec3dot3dot5-molecules-25-02525}

White, amorphous powder; $\left\lbrack \alpha \right\rbrack_{D}^{25}$+ 54.0 (*c* 0.1, MeOH); C~53~H~86~O~22~, HRESIMS *m*/*z*: 1097.5530 \[M + Na\]^+^ (calcd for \[C~53~H~86~O~22~Na\]^+^, 1097.5503); ^1^H (CD~3~OD, 400 MHz) and ^13^C NMR (CD~3~OD, 100 MHz) data, see [Table 2](#molecules-25-02525-t002){ref-type="table"}.

3.4. Acid Hydrolysis {#sec3dot4-molecules-25-02525}
--------------------

Each compound (**1**--**5**, 3.0 mg) was separately dissolved in 1.0 N HCl (dioxane---H~2~O, 1:1, *v*/*v*, 1.0 mL) and heated to 80 °C in a water bath for 3 h. The acidic solution was dried under N~2~ overnight. After extraction with CHCl~3~, the aqueous layer was dried using N~2~ to give aqueous residue (A). The aqueous residue (A) was separated by silica gel CC eluting with CH~2~Cl~2~--MeOH (10:1, *v*/*v*) and then further fractionated by RP-18 CC using a solvent gradient of MeOH--H~2~O (6:4, 7:3, and 8:2, *v*/*v*), to give the monosaccharides (50% yield). The specific rotations of these sugars were determined. The specific rotations ($\left\lbrack \alpha \right\rbrack_{D}^{25}$) of sugars was determined after dissolving in H~2~O for 24 h and compared to the literature (lit):D-cymarose: found +50.1 (*c* 0.4, H~2~O), lit +51.8 \[[@B14-molecules-25-02525]\]; D-oleandrose: found −12.1 (*c* 0.4, H~2~O), lit +11.7 \[[@B14-molecules-25-02525]\]; D-thevetose: found +40.3 (*c* 0.4, H~2~O); lit +42.3 \[[@B15-molecules-25-02525]\]; 6-deoxy-3-*O*-methyl-D-allose: found +10.9 (*c* 0.4, H~2~O); lit +10.0 \[[@B17-molecules-25-02525]\]; D-glucose: found + 49.2 (*c* 0.4, H~2~O); lit +48.0 \[[@B17-molecules-25-02525]\]. Based on the above evident, sugar components were found in: compounds **1** and **3**: D-cymarose, D-oleandrose, and D-thevetose; compounds **2** and **4**: D-cymarose, D-oleandrose, and 6-deoxy-3-*O*-methyl-D-allose; compound **5**: D-cymarose, D-oleandrose, D-thevetose, and D-glucose.

3.5. Alkaline Hydrolysis {#sec3dot5-molecules-25-02525}
------------------------

A solution of compound **1** (8 mg) in 1.0 mL of 5% KOH/MeOH was heated at 40 °C four 4 h and then neutralized with HCl 0.1 M. After that, the solution was partitioned with CHCl~3~ to give CHCl~3~ layer. CHCl~3~ layer was separated on HPLC system: J'sphere H-80 column (150 × 20 mm), solvent condition of 55% acetonitrile, to give sarcostin (54% yield). In a similar way, sarcostin was found as aglycone of compounds **2**--**5.**

3.6. α-Glucosidase Inhibitory Assay {#sec3dot6-molecules-25-02525}
-----------------------------------

The α-glucosidase (G0660-750UN, Sigma-Aldrich, St. Louis, MO) enzyme inhibition assay was performed according to the previously described method \[[@B11-molecules-25-02525]\]. The sample solution (2 mL dissolved in dimethyl sulfoxide (DMSO)) and 0.5 U/mL α-glucosidase (40 mL) were mixed in 120 mL of 0.1 M phosphate buffer (pH 7.0). After 5 min pre-incubation, 5 mM p-nitrophenyl-α-D-glucopyranoside solution (40 mL) was added, and the solution was incubated at 37 °C for 30 min. The absorbance of released 4-nitrophenol was measured at 405 nm by using a microplate reader (Molecular Devices, Sunnyvale, CA, USA).

3.7. α-Amylase Inhibitory Assay {#sec3dot7-molecules-25-02525}
-------------------------------

The α-amylase (A8220, Sigma-Aldrich, St. Louis, MO, USA) enzyme inhibitory activity was measured using the reported method \[[@B11-molecules-25-02525]\]. Substrate was prepared by boiling 100 mg potato starch in 5 mL phosphate buffer (pH 7.0) for 5 min, then cooling to room temperature. The samples (2 mL dissolved in DMSO) and substrate (50 mL) were mixed in 30 mL of 0.1 M phosphate buffer (pH 7.0). After 5 min pre-incubation, 5 mg/mL α-amylase solution (20 mL) was added, and the solution was incubated at 37 °C for 15 min. The reaction was stopped by adding 50 mL 1 M HCl and then 50 mL iodine solution was added. The absorbances were measured at 650 nm by a microplate reader.

4. Conclusions {#sec4-molecules-25-02525}
==============

In summary, five new pregnane glycosides and four known oleanane saponins were isolated and identified from *G. sylvestre*. Besides oleanane saponins-hightly species-specific of *G. sylvestre,* new pregnane glycosides in this report will provide secondary metabolisms as specific compounds in *Gymnema* genus. Compound **4** showed the weak α-glucosidase inhibitory activity. Compounds **2**, **3**, and **4** showed significant α-amylase inhibitory activity. This is the first report of α-amylase and α-glycosidase inhibitory activities of compounds from *G. sylvestre.*

**Sample Availability:** Samples of the compounds **1**--**9** are available from the authors.

Figure S1: The chemical structures of compounds **6**--**9**; Figure S2: HR-ESI-MS of compound **1**, Figure S3: ^1^H-NMR spectrum of compound **1**, Figure S4: ^13^C-NMR spectrum of compound **1**, Figure S5: DEPT135 spectrum of compound **1**, Figure S6: HSQC spectrum of compound **1**, Figure S7: HMBC spectrum of compound **1**, Figure S8: COSY spectrum of compound **1**, Figure S9: ROESY spectrum of compound **1**, Figure S10: HR-ESI-MS of compound **2**, Figure S11: ^1^H-NMR spectrum of compound **2**, Figure S12: ^13^C-NMR spectrum of compound **2**, Figure S13: DEPT135 spectrum of compound **2**, Figure S14: HSQC spectrum of compound **2**, Figure S15: HMBC spectrum of compound **2**, Figure S16: COSY spectrum of compound **2**, Figure S17: ROESY spectrum of compound **2**, Figure S18: HR-ESI-MS of compound **3**, Figure S19: ^1^H-NMR spectrum of compound **3**, Figure S20: ^13^C-NMR spectrum of compound **3**, Figure S21: HSQC spectrum of compound **3**, Figure S22: HMBC spectrum of compound **3**, Figure S23: COSY spectrum of compound **3**, Figure S24: ROESY spectrum of compound **3**, Figure S25: HR-ESI-MS of compound **4**, Figure S26: ^1^H-NMR spectrum of compound **4**, Figure S27: ^13^C-NMR spectrum of compound **4**, Figure S28: DEPT135 spectrum of compound **4**, Figure S29: HSQC spectrum of compound **4**, Figure S30: HMBC spectrum of compound **4**, Figure S31: COSY spectrum of compound **4**, Figure S32: ROESY spectrum of compound **4**, Figure S33: HR-ESI-MS of compound **5**, Figure S34: ^1^H-NMR spectrum of compound **5**, Figure S35: ^13^C-NMR spectrum of compound **5**, Figure S36: DEPT135 spectrum of compound **5**, Figure S37: HSQC spectrum of compound **5**; Figure S38: HMBC spectrum of compound **5**; Figure S39: COSY spectrum of compound **5**; Figure S40: ^1^H-NMR spectrum of compound **6**; Figure S41: ^13^C-NMR spectrum of compound **6**; Figure S42: HSQC spectrum of compound **6**; Figure S43: ^1^H-NMR spectrum of compound **7**; Figure S44: ^13^C-NMR spectrum of compound **7**; Figure S45: HSQC spectrum of compound **7**; Figure S46: ^1^H-NMR spectrum of compound **8**; Figure S47: ^13^C-NMR spectrum of compound **8**; Figure S48: HSQC spectrum of compound **8**; Figure S49: ^1^H-NMR spectrum of compound **9**; Figure S50: ^13^C-NMR spectrum of compound **9**; Figure S51: HSQC spectrum of compound **9**.
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Click here for additional data file.
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###### 

NMR spectroscopic data for compounds **1**--**3** in CD~3~OD.

  C                 1                                     2                                        3
  ------- --------- --------------------------- --------- --------------------------- ------------ -----------------------------
  1       39.8      1.09, m, α/1.80, m, *β*     39.8      1.09, m, α/1.79, m, *β*     39.8         1.09, m, α/1.80, m
  2       30.2      1.57, m, *β*/1.84, m, α     30.2      1.56, m, *β*/1.84, m, α     30.1         1.57, m, *β*/1.83, m, α
  3       79.2      3.50, m                     79.3      3.50, m                     79.3         3.49, m
  4       39.8      2.20, m, *β*/2.33, m, α     39.8      2.20, m, *β*/2.33, m, α     39.8         2.19, m, *β*/2.33, m, α
  5       140.0     \-                          140.0     \-                          140.0        \-
  6       120.0     5.32, br s                  120.0     5.32, br s                  119.9        5.33, br s
  7       35.2      2.11, m                     35.2      2.12, m                     35.2         2.12, m
  8       74.9      \-                          75.0      \-                          75.0         \-
  9       44.7      1.49, m                     44.7      1.48, m                     44.7         1.49, m
  10      38.0      \-                          38.0      \-                          38.0         \-
  11      26.0      1.63, m, α/2.00, m, *β*     26.0      1.62, m, α/2.00, m, *β*     25.9         1.62, m, α/2.00, m, *β*
  12      75.1      4.68, dd, 4.0, 11.6)        75.2      4.68, m                     75.2         4.70, dd, 4.0, 9.6)
  13      57.6      \-                          57.6      \-                          57.6         \-
  14      89.3      \-                          89.3      \-                          89.2         \-
  15      34.3      1.83, m, *β*/1.88, m, α     34.3      1.82, m, *β*/1.91, m, α     34.3         1.81, m, *β*/1.89, m, α
  16      33.5      1.74, m                     33.5      1.75, m                     33.5         1.74, m
  17      89.1      \-                          89.2      \-                          89.3         \-
  18      11.2      1.53, s                     11.2      1.53, s                     11.2         1.52, s
  19      18.5      1.13, s                     18.5      1.14, s                     18.5         1.14, s
  20      71.5      3.45, m                     71.5      3.44, m                     71.6         3.46, m
  21      18.9      1.05, d (6.4)               18.9      1.04, d (6.4)               18.9         1.06, d (6.4)
          **Tig**                               **Tig**                               **Tig**      
  1       169.1     \-                          169.2     \-                          169.1        \-
  2       130.0     \-                          130.1     \-                          130.1        \-
  3       139.5     6.98, q (7.2)               139.6     6.98, q (7.2)               139.6        7.00, q (6.8)
  4       14.5      1.80, d (7.2)               14.5      1.80, d (7.2)               14.5         1.81, d (6.8)
  5       12.2      1.85, s                     12.1      1.85, s                     12.1         1.87, s
          **Cym**                               **Cym**                               **Cym I**    
  1       97.2      4.84, br d (9.6)            97.2      4.85, br d (9.6)            97.2         4.84, br d, 9.6)
  2       36.6      1.52, m, *a*/2.05, m, *e*   36.7      1.53, m, *a*/2.04, m, *e*   36.6         1.55, m, *a*/2.05, m, *e*
  3       78.5      3.82, m                     78.5      3.83, m                     78.5         3.82, m
  4       83.8      3.24, m                     83.8      3.24, m                     83.8         3.23, m
  5       69.9      3.79, m                     70.0      3.79, m                     70.1         3.79, m
  6       18.5      1.19, d (6.0)               18.5      1.19, d (6.0)               18.5         1.18, d (6.4)
  3-OMe   58.5      3.42, s                     58.5      3.42, s                     58.5         3.42, s
          **Ole**                               **Ole**                               **Cym II**   
  1       102.6     4.57, br d (9.2)            102.6     4.56, br d (6.8)            101.2        4.78, br d (9.6)
  2       37.6      1.40, m, *a*/2.30, m, *e*   37.5      1.39, m, *a*/2.30, m, *e*   36.4         1.55, m, *a*/2.10, m, *e*
  3       80.2      3.36, m                     80.4      3.36, m                     78.6         3.82, m
  4       84.1      3.18, m                     84.0      3.17, m                     83.9         3.23, m
  5       72.5      3.36, m                     72.6      3.35, m                     69.9         3.79, m
  6       18.9      1.35, d (6.0)               19.0      1.34, d (6.0)               18.6         1.21, d (6.0)
  3-OMe   57.6      3.39, s                     57.5      3.39, s                     58.4         3.42, s
          **Thv**                               **All**                               **Ole**      
  1       104.3     4.41, br d (8.0)            102.2     4.70, br d (7.6)            102.6        4.58, br d (8.4)
  2       75.6      3.18, m                     73.6      3.29, m                     37.6         1.40, m, *a*)/2.30, m, *e*)
  3       87.7      3.00, t (6.8)               83.8      3.60, m                     80.2         3.36, m
  4       76.6      3.00, t (6.8)               75.0      3.16, m                     84.1         3.18, m
  5       73.2      3.25, m                     71.2      3.64, m                     72.5         3.35, m
  6       18.1      1.25, d (6.0)               18.5      1.21, d (6.0)               18.9         1.36, d (5.6)
  3-OMe   61.0      3.60, s                     62.5      3.58, s                     57.5         3.41, s
                                                                                      **Thv**      
  1       \-        \-                          \-        \-                          104.3        4.42, d (8.0)
  2       \-        \-                          \-        \-                          75.6         3.18, m
  3       \-        \-                          \-        \-                          87.7         3.00, m
  4       \-        \-                          \-        \-                          76.6         3.00, m
  5       \-        \-                          \-        \-                          73.2         3.25, m
  6       \-        \-                          \-        \-                          18.1         1.27, d (6.0)
  3-OMe   \-        \-                          \-        \-                          61.1         3.60, s

Assignments were done by Heteronuclear Single Quantum Coherence (HSQC), Heteronuclear Multiple Bond Correlation (HMBC), Correlation Spectroscopy (COSY), and Rotating frame Overhauser Effect Spectroscopy (ROESY) experiments. Tig, Tigloyl; Cym, β-[d]{.smallcaps}-cymaropyranosyl; Ole, β-[d]{.smallcaps}-oleandropyranosyl; Thv, β-[d]{.smallcaps}-thevetopyranosyl; All, 6-deoxy-3-*O*-methyl-β-[d]{.smallcaps}-allopyranosyl; *a*, axial; *e*, equatorial; *α*, atoms or groups laying below the plane of structure; *β*, atoms or groups laying above the plane of structure.

molecules-25-02525-t002_Table 2

###### 

NMR spectroscopic data for compounds **4** and **5** in CD~3~OD.

  C                    4                                     5
  ------- ------------ --------------------------- --------- ---------------------------
  1       39.8         1.07, m, α/1.79, m, *β*     39.8      1.08, m, α/1.80, m, *β*
  2       30.2         1.57, m, *β*/1.83, m, α     30.2      1.58, m, *β*/1.84, m, α
  3       79.3         3.50, m                     79.3      3.50, m
  4       39.8         2.18, m, *β*/2.33, m, α     39.8      2.20, m, *β*/2.33, m, α
  5       140.0        \-                          140.0     \-
  6       120.0        5.32, br s                  120.0     5.32, br s
  7       35.2         2.11, m                     35.2      2.11, m
  8       74.9         \-                          74.9      \-
  9       44.7         1.49, m                     44.7      1.49, m
  10      38.0         \-                          38.0      \-
  11      26.0         1.63, m, α/2.00, m, *β*     25.9      1.63, m, α/2.00, m, *β*
  12      75.1         4.67, m                     75.1      4.68, m
  13      57.6         \-                          57.6      \-
  14      89.3         \-                          89.3      \-
  15      34.3         1.80, m, *β*/1.88, m, α     34.3      1.83, m, *β*/1.90, m, α
  16      33.5         1.74, m                     33.5      1.75, m
  17      89.1         \-                          89.1      \-
  18      11.2         1.53, s                     11.2      1.53, s
  19      18.6         1.13, s                     18.6      1.12, s
  20      71.5         3.46, m                     71.5      3.45, m
  21      19.0         1.05, d (6.0)               18.9      1.05, d (6.4)
          **Tig**                                  **Tig**   
  1       169.1        \-                          169.1     \-
  2       130.1        \-                          130.1     \-
  3       139.5        6.98, q (7.2)               139.5     6.98, q (7.2)
  4       14.6         1.81, d (7.2)               14.5      1.80, d (7.2)
  5       12.2         1.85, s                     12.2      1.85, s
          **Cym I**                                **Cym**   
  1       97.2         4.83, br d (9.6)            97.2      4.84, br d (9.6)
  2       36.6         1.54, m, *a*/2.04, m, *e*   36.7      1.53, m, *a*/2.05, m, *e*
  3       78.5         3.82, m                     78.5      3.81, m
  4       83.8         3.24, m                     83.8      3.24, m
  5       69.8         3.78, m                     69.9      3.80, m
  6       18.3         1.17, d (6.4)               18.4      1.19, d (6.4)
  3-OMe   58.4         3.41, s                     58.5      3.42, s
          **Cym II**                               **Ole**   
  1       101.2        4.77, br d (9.6)            102.6     4.57, br d (9.2)
  2       36.4         1.54, m, *a*/2.04, m, *e*   37.6      1.40, m, *a*/2.30, m, *e*
  3       78.4         3.82, m                     80.3      3.35, m
  4       83.8         3.24, m                     84.1      3.18, m
  5       69.9         3.78, m                     72.6      3.38, m
  6       18.6         1.19, d (5.6)               18.8      1.36, d (6.0)
  3-OMe   58.5         3.40, s                     57.6      3.39, s
          **Ole**                                  **Thv**   
  1       102.6        4.56, br d (9.2)            104.2     4.43 (d (7.6)
  2       37.5         1.40, m/2.30, m             75.2      3.23, m
  3       80.3         3.35, m                     86.3      3.17, m
  4       83.7         3.18, m                     82.9      3.30, m
  5       72.5         3.35, m                     72.5      3.38, m
  6       18.9         1.35, d (6.0)               18.5      1.36, d (7.2)
  3-OMe   57.4         3.39, s                     61.2      3.60, s
          **All**                                  **Glc**   
  1       102.2        4.70, d (8.0)               104.3     4.41, d (7.6)
  2       73.5         3.29, m                     75.6      3.15, m
  3       83.9         3.60, m                     78.3      3.23, m
  4       75.0         3.16, m                     71.8      3.20, m
  5       71.2         3.63, m                     77.9      3.31, m
  6       18.6         1.21, d (6.0)               63.2      3.62, m/3.84, m
  3-OMe   62.5         3.58, s                               

Tig, Tigloyl; Cym, β-[d]{.smallcaps}-cymaropyranosyl; Ole, β-[d]{.smallcaps}-oleandropyranosyl; Thv, β-[d]{.smallcaps}-thevetopyranosyl; Glc, β-[d]{.smallcaps}-glucopyranosyl; All, 6-deoxy-3-*O*-methyl-β-[d]{.smallcaps}-allopyranosyl; *a*, axial; *e*, equatorial; *α*, atoms or groups laying below the plane of structure; *β*, atoms or groups laying above the plane of structure.
